Component 3: Schizophrenia — Eduqas A-Level Psychology
Test yourself on Component 3: Schizophrenia with EDUQAS A-Level practice questions.
Start free
7 days Premium · Then the free plan continues · No card, no charge
Your focus
- Biological explanations (at least two) (to include: For example cannabis influence on brain chemistry, dopamine hypothesis, enlarged ventricles)
- Individual differences explanations (at least two) (to include: For example thought disorder, schizophrenogenic mother, sex differences)
- Social Psychological Explanations (at least two) (to include: For example cultural norms, dysfunctional families, expressed emotion)
Show all 4 objectives
- Methods of modifying this behaviour (at least two) (to include: Including antipsychotic drugs, cognitive behavioral therapy)
Component 3: Schizophrenia exam tips
Quick Revision Summary (Key Takeaway)
Component 3 Schizophrenia explores the clinical characteristics, biological and psychological explanations, and contemporary treatments for schizophrenia under the Eduqas specification. Mastering this unit requires precise knowledge of classification systems, neurotransmitter hypotheses, cognitive deficits, and evidence-based interventions like antipsychotics and CBTp.
Topic Overview
The Schizophrenia option within Eduqas Component 3 investigates the complex clinical reality of a severe psychiatric disorder affecting approximately 1% of the global population. Students examine issues surrounding diagnosis and classification via DSM-5 and ICD-11, comparing biological explanations including genetics, the dopamine hypothesis, and neural correlates with psychological perspectives such as family dysfunction and cognitive deficits.
This topic connects foundational psychological debates, such as nature versus nurture, reductionism versus holism, and idiographic versus nomothetic approaches, to real-world clinical practice. By contrasting biological interventions like typical and atypical antipsychotics against therapies like CBTp and family therapy, learners develop a critical, evidence-based understanding of psychiatric intervention and modern interactionist frameworks.
Key Concepts
- →Classification and Diagnosis: Clinical characteristics, including positive symptoms (hallucinations, delusions) and negative symptoms (avolition, alogia, anhedonia), assessed through reliability (test-retest, inter-rater) and validity (co-morbidity, symptom overlap, gender and cultural bias).
- →Biological Aetiology: Polygenic inheritance (e.g., Ripke et al.), the revised dopamine hypothesis (hyperdopaminergia in subcortical areas vs. hypodopaminergia in cortical areas), and structural neural correlates like enlarged ventricles and reduced grey matter.
- →Psychological Formulations: Family dysfunction theories (Bateson's double-bind, high Expressed Emotion) and Frith's cognitive model of meta-representation and central control dysfunction.
- →Therapeutic Interventions: Typical (chlorpromazine) versus atypical (clozapine) antipsychotic drug therapy; Cognitive Behavioural Therapy for psychosis (CBTp), family therapy, and token economy systems within inpatient care.
Examiner Tips
- 💡Always cite named researchers and specific statistics where possible (e.g., Gottesman's twin study showing 48% concordance for MZ vs. 17% for DZ twins; Leucht et al.'s meta-analyses).
- 💡Structure evaluation points using PEEL (Point, Evidence, Explain, Link), explicitly linking back to how the evidence affects the clinical validity or real-world utility of the explanation or therapy.
- 💡Address issues of culture and gender bias in diagnostic validity questions, using examples such as elevated diagnosis rates of African-Caribbean individuals in the UK due to cultural misunderstandings of spiritual experiences.
Common Mistakes
- Believing schizophrenia equates to 'split personality' or dissociative identity disorder; in psychology, schizophrenia means 'split from reality', not multiple distinct personalities.
- Assuming biological treatments provide a permanent cure; antipsychotic medications manage symptoms by altering neurotransmission but do not eradicate the underlying biological or environmental vulnerabilities.
- Overlooking the difference between proximal and distal causes; cognitive and family dysfunction theories often explain how symptoms manifest (proximal), whereas biological factors generally explain the underlying vulnerability (distal).
Revision Plan
- 1Week 1, Days 1-2: Master clinical characteristics, diagnostic criteria (DSM vs. ICD), and debate issues of inter-rater reliability, co-morbidity, and cultural bias.
- 2Week 1, Days 3-5: Learn biological explanations (genetics, dopamine, neural correlates) alongside typical and atypical drug therapies, mapping out mechanisms and evaluations.
- 3Week 2, Days 1-3: Study psychological explanations (Bateson, Expressed Emotion, Frith's cognitive model) and psychological therapies (CBTp, family intervention, token economies).
- 4Week 2, Days 4-5: Synthesise the topic using the interactionist (diathesis-stress) model and practice timed past exam questions using specific Eduqas mark schemes.
Exam Question Types
- 📋Short-answer conceptual and application questions (2-4 marks): Defining specific symptoms or identifying explanations from clinical vignettes.
- 📋Methodological and data analysis questions (4-6 marks): Interpreting concordance rate tables, neuroimaging findings, or clinical trial outcome graphs.
- 📋Extended response essay questions (8-15 marks): Requiring balanced description (AO1) and sustained, critical evaluation (AO3) of an explanation, therapy, or diagnostic issue.
Command Word Expectations (EDUQAS)
Describe
Provide an accurate, detailed account of the key facts, theories, mechanisms, or research without offering critique, evaluation, or personal opinion (pure AO1).
Evaluate
Make reasoned judgments based on empirical evidence, methodological critique, and broader theoretical debates (AO3). You must weigh up strengths, limitations, and practical implications.
Discuss
A hybrid requirement combining balanced factual outline (AO1) with structured critical evaluation and contextual analysis (AO3), leading to an evidence-based conclusion.
How Students Lose Marks (Examiner Pitfalls)
Pitfall: Confusing positive and negative symptoms or describing them purely as 'good' and 'bad' experiences rather than additions or deficits to normal functioning.
❌ Weak Answer (Loses Marks):Positive symptoms are good things like hearing voices, while negative symptoms are bad things like feeling depressed and staying in bed.
Example improved answer:Positive symptoms represent an excess or distortion of normal functioning, such as hallucinations (sensory experiences without external stimuli) and delusions (unshakeable false beliefs). In contrast, negative symptoms represent a diminution or loss of normal functions, including avolition (apathy and lack of goal-directed behaviour) and speech poverty (alogia, characterized by reduced frequency and quality of verbal output).
Examiner Tip: Explicitly define positive as 'added behaviours' and negative as 'lost behaviours' using formal clinical terminology like alogia, avolition, and delusions of persecution or grandeur.
Pitfall: Failing to differentiate between traditional typical antipsychotics (e.g., chlorpromazine) and newer atypical antipsychotics (e.g., clozapine, risperidone), particularly regarding mechanism of action and side-effect profiles.
❌ Weak Answer (Loses Marks):Antipsychotic drugs cure schizophrenia by blocking dopamine receptors in the brain so the patient stops hearing voices.
Example improved answer:Typical antipsychotics such as chlorpromazine act primarily as dopamine antagonists, binding to and blocking post-synaptic D2 receptors in mesolimbic pathways to reduce positive symptoms; however, they carry severe extrapyramidal side effects such as tardive dyskinesia. Atypical antipsychotics such as clozapine temporarily block D2 receptors ('rapid dissociation') and additionally act as serotonin (5-HT2A) antagonists, effectively reducing both positive and negative symptoms with lower risk of motor side effects, though requiring monitoring for agranulocytosis.
Examiner Tip: Always specify the precise receptor pathways (e.g., D2 dopamine receptors, 5-HT2A serotonin receptors) and distinguish how typical versus atypical agents target positive versus negative symptoms.
Step-by-Step Worked Solutions
Question: Evaluate the dopamine hypothesis as a biological explanation for schizophrenia. (10 marks)
- 1.Step 1: Outline the core tenets of the original and updated dopamine hypothesis (hyperdopaminergia in the mesolimbic pathway causing positive symptoms; hypodopaminergia in the mesocortical pathway causing negative symptoms).
- 2.Step 2: Provide supporting research evidence (e.g., Leucht et al. meta-analysis on antipsychotic efficacy; amphetamine studies acting as dopamine agonists inducing psychotic episodes in non-clinical populations; Curran et al., 2004).
- 3.Step 3: Provide counter-evidence and neurochemical complexity (e.g., Ripke et al. genome-wide association studies showing other neurotransmitters like glutamate are heavily implicated; dopamine levels change quickly with drugs, but symptom relief takes weeks).
- 4.Step 4: Assess methodological limitations (correlational nature of post-mortem brain slices and PET scans, meaning cause and effect cannot be established without confounding variables like neuroleptic use).
- 5.Step 5: Synthesise with a balanced conclusion acknowledging that while dopamine is central, an interactionist perspective incorporating neurodevelopmental and environmental triggers is necessary.
Final Answer: A complete 10-mark answer balances detailed neurochemical explanation of distinct dopamine pathways with robust empirical support (antipsychotic trials and agonist studies) and critical evaluation highlighting non-dopaminergic mechanisms, delayed therapeutic onset, and biological reductionism.
Question: Explain one cognitive explanation of schizophrenia and evaluate its usefulness. (8 marks)
- 1.Step 1: Detail Frith's (1992) cognitive model of schizophrenia, specifying deficits in meta-representation (ability to reflect on thoughts, intentions, and inner speech) and central control (ability to suppress automatic responses).
- 2.Step 2: Explain how impaired meta-representation produces delusions of control and auditory hallucinations, while impaired central control results in derailment and disorganized speech.
- 3.Step 3: Evaluate usefulness by demonstrating practical application: Frith's cognitive framework underpins Cognitive Behavioural Therapy for psychosis (CBTp), helping patients reality-test beliefs and reduce distress.
- 4.Step 4: Evaluate limitations: Cognitive explanations describe the proximal causes (the cognitive mechanics of symptoms) rather than the distal causes (why the cognitive dysfunction originated initially, which is likely neurobiological).
Final Answer: A high-scoring response accurately details Frith's mechanisms of meta-representation and central control, links them to specific symptoms, validates the model through CBTp therapeutic success, and critiques it for addressing proximal symptoms rather than underlying aetiology.
Active Recall Memory Test
What are the concordance rates for schizophrenia in monozygotic (MZ) versus dizygotic (DZ) twins according to Gottesman (1991)?
Key Fact: 48% concordance in monozygotic (identical) twins compared to 17% in dizygotic (fraternal) twins.
What are the two cognitive deficits identified in Frith's (1992) model of schizophrenia?
Key Fact: Deficits in meta-representation (reflecting on one's own thoughts and actions) and deficits in central control (suppressing automatic cognitive responses).
How does the pharmacological action of atypical antipsychotics differ from typical antipsychotics?
Key Fact: Typical antipsychotics (e.g., chlorpromazine) solely act as dopamine D2 antagonists; atypical antipsychotics (e.g., clozapine) act as dopamine D2 antagonists with rapid dissociation while also antagonising serotonin 5-HT2A receptors.
What are the three core elements of high Expressed Emotion (EE) in family systems?
Key Fact: Verbal criticism (often accompanied by hostility), anger/rejection, and emotional over-involvement (intrusive overprotection).
Frequently Asked Questions
What is the difference between positive and negative symptoms in schizophrenia?
Positive symptoms refer to excess experiences or behaviours added to normal functioning, including hallucinations, delusions, and disorganized speech. Negative symptoms refer to a deficits or reductions in normal capability, such as avolition (loss of motivation), alogia (poverty of speech), and anhedonia (loss of pleasure). Both types are assessed in clinical diagnosis under DSM-5 and ICD-11.
Why is the dopamine hypothesis considered reductionist?
The dopamine hypothesis is biologically reductionist because it attempts to explain a highly complex, multi-faceted mental disorder purely through the dysregulation of a single neurotransmitter. While hyperdopaminergia in the mesolimbic pathway accounts for many positive symptoms, it overlooks psychosocial stressors, childhood trauma, and broader neurochemical networks including glutamate, serotonin, and GABA pathways. Modern clinical psychology favours an interactionist approach combining biological vulnerabilities with environmental stress.
How does family therapy help reduce schizophrenia relapse?
Family therapy aims to alter interpersonal dynamics in the patient's domestic environment by reducing Expressed Emotion (EE). It educates family members on the biological nature of the disorder, establishes realistic expectations, improves constructive problem-solving skills, and reduces unhelpful hostility or emotional over-involvement. Lowering household tension reduces psychological stress for the patient, which substantially decreases the neurochemical arousal that triggers relapse.
What does the diathesis-stress model argue regarding schizophrenia?
The diathesis-stress model proposes that schizophrenia develops from a combination of an underlying vulnerability (diathesis) and an environmental trigger (stress). In modern formulations, the diathesis is not a single gene but a polygenic vulnerability combined with early neurodevelopmental trauma. The stressor can be psychological (such as severe family conflict or abuse) or biological (such as cannabis abuse, which affects dopamine transmission), meaning neither factor alone is typically sufficient to cause the disorder.
What is co-morbidity and why does it threaten diagnostic validity in schizophrenia?
Co-morbidity occurs when two or more distinct medical or psychiatric disorders occur simultaneously in the same patient (e.g., schizophrenia and severe depression or substance abuse). Buckley et al. (2009) found that approximately 50% of schizophrenia patients also suffer from co-morbid depression. This challenges diagnostic validity because clinicians may struggle to determine whether symptoms represent a single complex condition or distinct separate disorders, potentially leading to misdiagnosis or inappropriate treatment plans.